Literature DB >> 2266496

Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.

M L Huang1, W J Jusko.   

Abstract

The pharmacokinetics of prednisolone and prednisone were examined in 32 rats at four intravenous doses (5, 10, 25, and 50 mg/kg). Each rat was given one dose of either intravenous prednisolone or prednisone, and plasma concentrations of both compounds were measured by HPLC. Mammillary moment analysis showed the apparent clearance and volume of distribution of prednisolone and the apparent clearance of prednisone to be dose-dependent. Further diagnostic analysis using a linear interconversion model revealed modest interconversion between the two steroids and at least two saturable clearance processes: the conversion of prednisolone to prednisone and the irreversible elimination of prednisone. A comprehensive model which incorporates the nonlinear clearances of prednisolone and prednisone plus the additional feature of nonlinear tissue distribution of prednisolone was then constructed. Four differential equations describing the rate of change of each steroid in each compartment were used to numerically fit by nonlinear least squares analysis all plasma concentration-time profiles simultaneously. The final estimates from the full model only partly agreed with the results from the two moment analyses but confirmed the general structure of the model. The nonlinear tissue distribution of prednisolone was reinforced by assay of muscle tissue. This study demonstrates the utility of the model-building process where simpler models yield insights into more elaborate schemes with complex nonlinear features.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266496     DOI: 10.1007/bf01061702

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  16 in total

1.  Second generation model for prednisolone pharmacodynamics in the rat.

Authors:  A I Nichols; F D Boudinot; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

2.  Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

3.  On the difficulties of fitting the double Michaelis-Menten equation to kinetic data.

Authors:  J H Bates; D A Bates; W Mackillop
Journal:  J Theor Biol       Date:  1987-03-21       Impact factor: 2.691

4.  The non-linear pharmacokinetics of prednisone and prednisolone. I. Theoretical.

Authors:  J J Ferry; J G Wagner
Journal:  Biopharm Drug Dispos       Date:  1986 Jan-Feb       Impact factor: 1.627

5.  Corticosteroid analysis in biological fluids by high-performance liquid chromatography.

Authors:  J Q Rose; W J Jusko
Journal:  J Chromatogr       Date:  1979-03-01

6.  Mean residence time for drugs subject to reversible metabolism.

Authors:  L Aarons
Journal:  J Pharm Pharmacol       Date:  1987-07       Impact factor: 3.765

7.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

8.  Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.

Authors:  J G Wagner; G J Szpunar; J J Ferry
Journal:  Biopharm Drug Dispos       Date:  1985 Apr-Jun       Impact factor: 1.627

9.  Serum protein binding of prednisolone in four species.

Authors:  M L Rocci; N F Johnson; W J Jusko
Journal:  J Pharm Sci       Date:  1980-08       Impact factor: 3.534

10.  Prednisolone clearance at steady state in man.

Authors:  U F Legler; F J Frey; L Z Benet
Journal:  J Clin Endocrinol Metab       Date:  1982-10       Impact factor: 5.958

View more
  6 in total

1.  Physiologically Based Pharmacokinetic Modeling Involving Nonlinear Plasma and Tissue Binding: Application to Prednisolone and Prednisone in Rats.

Authors:  Xiaonan Li; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2020-09-03       Impact factor: 4.030

Review 2.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

3.  Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone.

Authors:  Jian Xu; Julia Winkler; Sreedharan Nair Sabarinath; Hartmut Derendorf
Journal:  AAPS J       Date:  2008-06-25       Impact factor: 4.009

4.  Effect of corticosteroid binding globulin on the pharmacokinetics of prednisolone in rats.

Authors:  H C Ko; R R Almon; W J Jusko
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

5.  A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma.

Authors:  J Xu; J Winkler; H Derendorf
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-02-23       Impact factor: 2.410

Review 6.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.